Works matching AU Faramarzi, Mohammad


Results: 235
    1
    2
    3

    New phenylthiosemicarbazide‐phenoxy‐1,2,3‐triazole‐N‐phenylacetamides as dual inhibitors against α‐glucosidase and PTP‐1B for the treatment of type 2 diabetes.

    Published in:
    Archiv der Pharmazie, 2024, v. 357, n. 7, p. 1, doi. 10.1002/ardp.202300517
    By:
    • Ansariashlaghi, Shirin;
    • Fakhrioliaei, Azadeh;
    • Mohammadi‐Khanaposhtani, Maryam;
    • Noori, Milad;
    • Asadi, Mehdi;
    • Mojtabavi, Somayeh;
    • Faramarzi, Mohammad A.;
    • Esfahani, Ensieh N.;
    • Rastegar, Hossein;
    • Larijani, Bagher;
    • Azizian, Homa;
    • Mahdavi, Mohammad
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10

    Design, Synthesis, and Biological Evaluation of New Indole-Acrylamide-1,2,3-Triazole Derivatives as Potential α-Glucosidase Inhibitors.

    Published in:
    Polycyclic Aromatic Compounds, 2022, v. 42, n. 6, p. 3157, doi. 10.1080/10406638.2020.1854323
    By:
    • Sadat-Ebrahimi, Seyed Esmaeil;
    • Babania, Hiva;
    • Mohammadi-Khanaposhtani, Maryam;
    • Asgari, Mohammad Sadegh;
    • Mojtabavi, Somayeh;
    • Faramarzi, Mohammad Ali;
    • Yahya-Meymandi, Azadeh;
    • Zareie, Samaneh;
    • Larijani, Bagher;
    • Biglar, Mahmoud;
    • Rastgar, Hossein;
    • Foroumadi, Alireza;
    • Mahdavi, Mohammad
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Aryl-quinoline-4-carbonyl hydrazone bearing different 2-methoxyphenoxyacetamides as potent α-glucosidase inhibitors; molecular dynamics, kinetic and structure–activity relationship studies.

    Published in:
    Scientific Reports, 2024, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-50395-8
    By:
    • Hamedifar, Haleh;
    • Mirfattahi, Mahroo;
    • Khalili Ghomi, Minoo;
    • Azizian, Homa;
    • Iraji, Aida;
    • Noori, Milad;
    • Moazzam, Ali;
    • Dastyafteh, Navid;
    • Nokhbehzaim, Ali;
    • Mehrpour, Katayoun;
    • Javanshir, Shahrzad;
    • Mojtabavi, Somayeh;
    • Faramarzi, Mohammad Ali;
    • Larijani, Bagher;
    • Hajimiri, Mir Hamed;
    • Mahdavi, Mohammad
    Publication type:
    Article
    17
    18

    Imidazo[1,2-c]quinazolines as a novel and potent scaffold of α-glucosidase inhibitors: design, synthesis, biological evaluations, and in silico studies.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42549-5
    By:
    • Peytam, Fariba;
    • Hosseini, Faezeh sadat;
    • Hekmati, Malak;
    • Bayati, Bahareh;
    • Moghadam, Mahdis Sadeghi;
    • Emamgholipour, Zahra;
    • Firoozpour, Loghman;
    • Mojtabavi, Somayeh;
    • Faramarzi, Mohammad Ali;
    • Sadat-Ebrahimi, Seyed Esmaeil;
    • Tehrani, Maliheh Barazandeh;
    • Foroumadi, Alireza
    Publication type:
    Article
    19

    Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidase.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39424-8
    By:
    • Yousefnejad, Faeze;
    • Mohammadi-Moghadam-Goozali, Mahyar;
    • Sayahi, Mohammad Hosein;
    • Halimi, Mohammad;
    • Moazzam, Ali;
    • Mohammadi-Khanaposhtani, Maryam;
    • Mojtabavi, Somayeh;
    • Asadi, Mehdi;
    • Faramarzi, Mohammad Ali;
    • Larijani, Bagher;
    • Amanlou, Massoud;
    • Mahdavi, Mohammad
    Publication type:
    Article
    20

    Design, synthesis, in vitro anti-α-glucosidase evaluations, and computational studies of new phthalimide-phenoxy-1,2,3-triazole-N-phenyl (or benzyl) acetamides as potential anti-diabetic agents.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36890-y
    By:
    • Emadi, Mehdi;
    • Halimi, Mohammad;
    • Moazzam, Ali;
    • Hosseini, Samanesadat;
    • Mojtabavi, Somayeh;
    • Faramarzi, Mohammad Ali;
    • Ghadimi, Reza;
    • Moghadamnia, Ali Akbar;
    • Nasli-Esfahani, Ensieh;
    • Mohammadi-Khanaposhtani, Maryam;
    • Mahdavi, Mohammad
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91473-z
    By:
    • Peytam, Fariba;
    • Takalloobanafshi, Ghazaleh;
    • Saadattalab, Toktam;
    • Norouzbahari, Maryam;
    • Emamgholipour, Zahra;
    • Moghimi, Setareh;
    • Firoozpour, Loghman;
    • Bijanzadeh, Hamid Reza;
    • Faramarzi, Mohammad Ali;
    • Mojtabavi, Somayeh;
    • Rashidi-Ranjbar, Parviz;
    • Karima, Saeed;
    • Pakraad, Roya;
    • Foroumadi, Alireza
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50